CLATAZEV Trademark

Trademark Overview

On Monday, February 13, 2017, a trademark application was filed for CLATAZEV with the United States Patent and Trademark Office. The USPTO has given the CLATAZEV trademark a serial number of 87333842. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 29, 2021. This trademark is owned by Bristol-Myers Squibb Company. The CLATAZEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
clatazev

General Information

Serial Number87333842
Word MarkCLATAZEV
Filing DateMonday, February 13, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 29, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 17, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, March 29, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 29, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020EXTENSION 5 GRANTED
Thursday, August 20, 2020EXTENSION 5 FILED
Friday, August 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 20, 2020TEAS EXTENSION RECEIVED
Thursday, February 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2020EXTENSION 4 GRANTED
Tuesday, February 4, 2020EXTENSION 4 FILED
Tuesday, February 4, 2020TEAS EXTENSION RECEIVED
Thursday, August 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2019EXTENSION 3 GRANTED
Monday, August 19, 2019EXTENSION 3 FILED
Monday, August 19, 2019TEAS EXTENSION RECEIVED
Friday, February 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 13, 2019EXTENSION 2 GRANTED
Wednesday, February 13, 2019EXTENSION 2 FILED
Wednesday, February 13, 2019TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 10, 2018EXTENSION 1 GRANTED
Friday, August 10, 2018EXTENSION 1 FILED
Friday, August 10, 2018TEAS EXTENSION RECEIVED
Tuesday, February 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 15, 2017ASSIGNED TO LIE
Friday, November 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 9, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, May 9, 2017PRIORITY ACTION E-MAILED
Tuesday, May 9, 2017PRIORITY ACTION WRITTEN
Monday, May 8, 2017ASSIGNED TO EXAMINER
Friday, February 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 16, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

clatazev diseases pharmaceutical human anti preparations disorders organ solid auto immune